Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

The Finnish New Variant of Chlamydia trachomatis with a Single Nucleotide Polymorphism in the 23S rRNA Target Escapes Detection by the Aptima Combo 2 Test.

Hokynar K, Rantakokko-Jalava K, Hakanen A, Havana M, Mannonen L, Jokela P, Kurkela S, Lappalainen M, Unemo M, Puolakkainen M.

Microorganisms. 2019 Jul 31;7(8). pii: E227. doi: 10.3390/microorganisms7080227.

2.

Chlamydia trachomatis samples testing falsely negative in the Aptima Combo 2 test in Finland, 2019.

Rantakokko-Jalava K, Hokynar K, Hieta N, Keskitalo A, Jokela P, Muotiala A, Jokiranta TS, Kuusela R, Sarkkinen H, Aittoniemi J, Vuorinen T, Hakanen AJ, Puolakkainen M.

Euro Surveill. 2019 May;24(22). doi: 10.2807/1560-7917.ES.2019.24.22.1900298.

3.

Rapid time-resolved luminescence based screening of bacteria in urine with luminescence modulating biosensing phages.

Kulpakko J, Rantakokko-Jalava K, Eerola E, Hänninen PE.

Anal Biochem. 2019 Apr 1;570:21-26. doi: 10.1016/j.ab.2019.01.011. Epub 2019 Feb 5.

PMID:
30735666
4.

Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.

Haldorsen B, Giske CG, Hansen DS, Orri Helgason K, Kahlmeter G, Löhr IH, Matuschek E, Österblad M, Rantakokko-Jalava K, Wang M, Småbrekke L, Samuelsen Ø, Sundsfjord A.

J Antimicrob Chemother. 2018 Oct 1;73(10):2905. doi: 10.1093/jac/dky339. No abstract available.

5.

Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.

Haldorsen B, Giske CG, Hansen DS, Helgason KO, Kahlmeter G, Löhr IH, Matuschek E, Österblad M, Rantakokko-Jalava K, Wang M, Småbrekke L, Samuelsen Ø, Sundsfjord A; NordicAST CPE Study Group.

J Antimicrob Chemother. 2018 Oct 1;73(10):2738-2747. doi: 10.1093/jac/dky276. Erratum in: J Antimicrob Chemother. 2018 Oct 1;73(10):2905.

6.

The first human report of mobile colistin resistance gene, mcr-1, in Finland.

Gröndahl-Yli-Hannuksela K, Lönnqvist E, Kallonen T, Lindholm L, Jalava J, Rantakokko-Jalava K, Vuopio J.

APMIS. 2018 May;126(5):413-417. doi: 10.1111/apm.12834.

PMID:
29696722
7.

Aetiology of febrile pharyngitis in children: Potential of myxovirus resistance protein A (MxA) as a biomarker of viral infection.

Ivaska L, Niemelä J, Lempainen J, Österback R, Waris M, Vuorinen T, Hytönen J, Rantakokko-Jalava K, Peltola V.

J Infect. 2017 Apr;74(4):385-392. doi: 10.1016/j.jinf.2017.01.002. Epub 2017 Jan 7.

PMID:
28077283
8.

Improved Differentiation of Streptococcus pneumoniae and Other S. mitis Group Streptococci by MALDI Biotyper Using an Improved MALDI Biotyper Database Content and a Novel Result Interpretation Algorithm.

Harju I, Lange C, Kostrzewa M, Maier T, Rantakokko-Jalava K, Haanperä M.

J Clin Microbiol. 2017 Mar;55(3):914-922. doi: 10.1128/JCM.01990-16. Epub 2017 Jan 4.

9.

Integrated Acoustic Separation, Enrichment, and Microchip Polymerase Chain Reaction Detection of Bacteria from Blood for Rapid Sepsis Diagnostics.

Ohlsson P, Evander M, Petersson K, Mellhammar L, Lehmusvuori A, Karhunen U, Soikkeli M, Seppä T, Tuunainen E, Spangar A, von Lode P, Rantakokko-Jalava K, Otto G, Scheding S, Soukka T, Wittfooth S, Laurell T.

Anal Chem. 2016 Oct 4;88(19):9403-9411. Epub 2016 Sep 14.

PMID:
27264110
10.

Comprehensive real-time epidemiological data from respiratory infections in Finland between 2010 and 2014 obtained from an automated and multianalyte mariPOC® respiratory pathogen test.

Gunell M, Antikainen P, Porjo N, Irjala K, Vakkila J, Hotakainen K, Kaukoranta SS, Hirvonen JJ, Saha K, Manninen R, Forsblom B, Rantakokko-Jalava K, Peltola V, Koskinen JO, Huovinen P.

Eur J Clin Microbiol Infect Dis. 2016 Mar;35(3):405-13. doi: 10.1007/s10096-015-2553-0. Epub 2016 Jan 6.

PMID:
26740322
11.

Ready to use dry-reagent PCR assays for the four common bacterial pathogens using switchable lanthanide luminescence probe system.

Lehmusvuori A, Soikkeli M, Tuunainen E, Seppä T, Spangar A, Rantakokko-Jalava K, von Lode P, Karhunen U, Soukka T, Wittfooth S.

J Microbiol Methods. 2015 Nov;118:64-9. doi: 10.1016/j.mimet.2015.08.022. Epub 2015 Sep 3.

PMID:
26342433
12.

Use of an automated PCR assay, the GenomEra S. pneumoniae, for rapid detection of Streptococcus pneumoniae in blood cultures.

Hirvonen JJ, Seiskari T, Harju I, Rantakokko-Jalava K, Vuento R, Aittoniemi J.

Infect Dis (Lond). 2015;47(11):796-800. doi: 10.3109/23744235.2015.1063157. Epub 2015 Jul 10.

PMID:
26162002
13.

Candida dubliniensis spondylodiscitis in an immunocompetent patient. Case report and review of the literature.

Oksi J, Finnilä T, Hohenthal U, Rantakokko-Jalava K.

Med Mycol Case Rep. 2013 Nov 13;3:4-7. doi: 10.1016/j.mmcr.2013.11.001. eCollection 2014 Jan.

14.

Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of viridans group streptococci.

Kärpänoja P, Harju I, Rantakokko-Jalava K, Haanperä M, Sarkkinen H.

Eur J Clin Microbiol Infect Dis. 2014 May;33(5):779-88. doi: 10.1007/s10096-013-2012-8. Epub 2013 Nov 8.

PMID:
24202732
15.

Homogeneous duplex polymerase chain reaction assay using switchable lanthanide fluorescence probes.

Lehmusvuori A, Tapio AH, Mäki-Teeri P, Rantakokko-Jalava K, Wang Q, Takalo H, Soukka T.

Anal Biochem. 2013 May 1;436(1):16-21. doi: 10.1016/j.ab.2013.01.007. Epub 2013 Jan 24.

PMID:
23353013
16.
17.

Rapid confirmation of suspected methicillin-resistant Staphylococcus aureus colonies on chromogenic agars by a new commercial PCR assay, the GenomEra MRSA/SA Diagnose.

Hirvonen JJ, Nevalainen M, Tissari P, Salmenlinna S, Rantakokko-Jalava K, Kaukoranta SS.

Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1961-8. doi: 10.1007/s10096-011-1527-0. Epub 2012 Jan 26.

PMID:
22278292
18.

Rapid homogeneous PCR assay for the detection of Chlamydia trachomatis in urine samples.

Lehmusvuori A, Juntunen E, Tapio AH, Rantakokko-Jalava K, Soukka T, Lövgren T.

J Microbiol Methods. 2010 Dec;83(3):302-6. doi: 10.1016/j.mimet.2010.09.018. Epub 2010 Oct 1.

PMID:
20888867
19.

Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia.

Kainulainen L, Vuorinen T, Rantakokko-Jalava K, Osterback R, Ruuskanen O.

J Allergy Clin Immunol. 2010 Jul;126(1):120-6. doi: 10.1016/j.jaci.2010.04.016. Epub 2010 Jun 11.

PMID:
20541246
20.

Three distinct episodes of GBS septicemia in a healthy newborn during the first month of life.

Soukka H, Rantakokko-Jalava K, Vähäkuopus S, Ruuskanen O.

Eur J Pediatr. 2010 Oct;169(10):1275-7. doi: 10.1007/s00431-010-1187-6. Epub 2010 Mar 25.

PMID:
20336465
21.

Rapid field detection assays for Bacillus anthracis, Brucella spp., Francisella tularensis and Yersinia pestis.

Matero P, Hemmilä H, Tomaso H, Piiparinen H, Rantakokko-Jalava K, Nuotio L, Nikkari S.

Clin Microbiol Infect. 2011 Jan;17(1):34-43. doi: 10.1111/j.1469-0691.2010.03178.x.

22.

Induced sputum in the diagnosis of childhood community-acquired pneumonia.

Lahti E, Peltola V, Waris M, Virkki R, Rantakokko-Jalava K, Jalava J, Eerola E, Ruuskanen O.

Thorax. 2009 Mar;64(3):252-7. doi: 10.1136/thx.2008.099051. Epub 2008 Dec 3.

PMID:
19052043
23.

Quantification of Ureaplasma urealyticum DNA in the amniotic fluid from patients in PTL and pPROM and its relation to inflammatory cytokine levels.

Jacobsson B, Aaltonen R, Rantakokko-Jalava K, Morken NH, Alanen A.

Acta Obstet Gynecol Scand. 2009;88(1):63-70. doi: 10.1080/00016340802572646.

PMID:
19031281
24.

Imported tungiasis in a Finnish journalist: the first case reported from the Nordic countries.

Jalava-Karvinen P, Marttila H, Talve L, Rantakokko-Jalava K, Jokiranta S, Kotilainen P.

APMIS. 2008 Mar;116(3):219-22. doi: 10.1111/j.1600-0463.2008.00933.x.

PMID:
18377589
26.

Negative impact of Aspergillus galactomannan and DNA detection in the diagnosis of fungal rhinosinusitis.

Kostamo K, Richardson M, Eerola E, Rantakokko-Jalava K, Meri T, Malmberg H, Toskala E.

J Med Microbiol. 2007 Oct;56(Pt 10):1322-7.

PMID:
17893168
27.

In vitro susceptibility of viridans group streptococci isolated from blood in southwest Finland in 1993-2004.

Lindgren M, Jalava J, Rantakokko-Jalava K, Meurman O.

Scand J Infect Dis. 2007;39(6-7):508-13.

PMID:
17577811
28.

Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2.

Haanperä M, Jalava J, Huovinen P, Meurman O, Rantakokko-Jalava K.

J Clin Microbiol. 2007 Mar;45(3):762-70. Epub 2007 Jan 10.

29.

Aetiological diagnosis of infective endocarditis by direct amplification of rRNA genes from surgically removed valve tissue. An 11-year experience in a Finnish teaching hospital.

Kotilainen P, Heiro M, Jalava J, Rantakokko V, Nikoskelainen J, Nikkari S, Rantakokko-Jalava K.

Ann Med. 2006;38(4):263-73.

PMID:
16754257
30.

Brain abscess caused by Mycoplasma hominis: a clinically recognizable entity?

Kupila L, Rantakokko-Jalava K, Jalava J, Peltonen R, Marttila RJ, Kotilainen E, Kotilainen P.

Eur J Neurol. 2006 May;13(5):550-1. No abstract available.

PMID:
16722987
31.

Evaluation of Vitek 2 for identification of yeasts in the clinical laboratory.

Meurman O, Koskensalo A, Rantakokko-Jalava K.

Clin Microbiol Infect. 2006 Jun;12(6):591-3.

33.

Bronchoalveolar lavage in immunocompromised patients with haematological malignancy--value of new microbiological methods.

Hohenthal U, Itälä M, Salonen J, Sipilä J, Rantakokko-Jalava K, Meurman O, Nikoskelainen J, Vainionpää R, Kotilainen P.

Eur J Haematol. 2005 Mar;74(3):203-11.

PMID:
15693789
34.

Diagnostic value of bronchoalveolar lavage in community-acquired pneumonia in a routine setting: a study on patients treated in a Finnish university hospital.

Hohenthal U, Sipilä J, Vainionpää R, Meurman O, Rantakokko-Jalava K, Nikoskelainen J, Kotilainen P.

Scand J Infect Dis. 2004;36(3):198-203.

PMID:
15119365
35.

Application of Bacillus anthracis PCR to simulated clinical samples.

Rantakokko-Jalava K, Viljanen MK.

Clin Microbiol Infect. 2003 Oct;9(10):1051-6.

36.

Semiquantitative detection by real-time PCR of Aspergillus fumigatus in bronchoalveolar lavage fluids and tissue biopsy specimens from patients with invasive aspergillosis.

Rantakokko-Jalava K, Laaksonen S, Issakainen J, Vauras J, Nikoskelainen J, Viljanen MK, Salonen J.

J Clin Microbiol. 2003 Sep;41(9):4304-11.

37.

Aetiological diagnosis of brain abscesses and spinal infections: application of broad range bacterial polymerase chain reaction analysis.

Kupila L, Rantakokko-Jalava K, Jalava J, Nikkari S, Peltonen R, Meurman O, Marttila RJ, Kotilainen E, Kotilainen P.

J Neurol Neurosurg Psychiatry. 2003 Jun;74(6):728-33.

38.

Negative bacterial polymerase chain reaction (PCR) findings in prostate tissue from patients with symptoms of chronic pelvic pain syndrome (CPPS) and localized prostate cancer.

Leskinen MJ, Rantakokko-Jalava K, Manninen R, Leppilahti M, Marttila T, Kylmälä T, Tammela TL.

Prostate. 2003 May 1;55(2):105-10.

PMID:
12661035
39.

Optimal DNA isolation method for detection of bacteria in clinical specimens by broad-range PCR.

Rantakokko-Jalava K, Jalava J.

J Clin Microbiol. 2002 Nov;40(11):4211-7.

40.
41.

LCx Mycobacterium tuberculosis assay is valuable with respiratory specimens, but provides little help in the diagnosis of extrapulmonary tuberculosis.

Rantakokko-Jalava K, Marjamäki M, Marttila H, Mäkelä L, Valtonen V, Viljanen MK.

Ann Med. 2001 Feb;33(1):55-62.

PMID:
11310940
42.

Direct amplification of rRNA genes in diagnosis of bacterial infections.

Rantakokko-Jalava K, Nikkari S, Jalava J, Eerola E, Skurnik M, Meurman O, Ruuskanen O, Alanen A, Kotilainen E, Toivanen P, Kotilainen P.

J Clin Microbiol. 2000 Jan;38(1):32-9.

Supplemental Content

Loading ...
Support Center